Cardiac Surgery
Extracorporeal life support (ECLS)
Unstoppable — Together, with our partners in healthcare, we are advancing ECLS therapy.
In Memoriam of Dr. Robert H. Bartlett
1939–2025
We honor Dr. Robert Bartlett, a pioneering physician whose groundbreaking work with extracorporeal membrane oxygenation (ECMO) has saved countless lives. His legacy demonstrates the impact of collaboration between clinicians and engineers in advancing patient care. We are grateful for his lasting contributions to healthcare and for the difference he has made through lifesaving innovation.
Medtronic Cardiac Surgery Team
All in on ECMO
Providing products designed specifically for ECMO and a wide breadth of support products that can be used with patients in critical care settings
- Collaborating with clinical teams, hospital systems, and societies to optimize and simplify technologies and processes
- Supporting evidence generation and excellence in education
ECMO system
Designed for simplicity and performance, the VitalFlow™ ECMO system can be configured to accommodate your clinical preferences and hospital protocols.1
ECMO oxygenators
Innovative flow-path design and real-time device diagnostic capabilities are designed for long-term performance.†,2
ECMO access solutions
Catheters designed for the duration and support requirements of patients on VV and/or VA ECMO3
ECMO stories
ECMO patient stories
Ben’s journey from ECMO to IRONMAN finisher
Carlos and Grace’s COVID-19 journey — from ECMO to marriage
ECMO clinical stories
Starting an ECMO center
Medtronic Cardiac Surgery
With every beat, expect more.
Medtronic Academy
Find additional feature information along with a variety of educational resources and tools.
Cardiovascular Lifeline Technical Services
- Phone: 877-526-7890
- Phone: 763-526-7890
Potential complications related to the use of ECMO devices include, but are not limited to, heart, vessel, or lung damage, hypoxia, anemia, irritation, toxic reaction, infection, hemorrhage, liver or kidney failure, stroke, and death. The benefits of extracorporeal support must be weighed against the risk of systemic anticoagulation and must be assessed by the prescribing physician.
The benefits of catheterization for extracorporeal circulation must be weighed against the risk of systemic anticoagulation and subsequent propensity for hemorrhage.
† Indicated in the United States for use up to 48 hours.
1. Medtronic design verification data on file. Data may not be indicative of clinical performance.
2. Data on file. Design verification and validation reports. These tests may not be indicative of clinical performance.
3. Data on file. Design verification report. These tests may not be indicative of clinical performance.